Stereotaxic radiotherapy of primary extracranial tumors

被引:2
作者
Giraud, P. [7 ]
Lerouge, D. [1 ]
Latorzeff, I [2 ]
Mirabel, X. [3 ]
Dohan, A. [4 ]
Mordant, P. [5 ]
de Longchamps, N. Barry [6 ]
机构
[1] Ctr Francois Baclesse, Dept Radiotherapie, Ave Gen Harris, F-14076 Caen, France
[2] Clin Pasteur, Dept Radiotherapie Oncol, Batiment Atrium,1 Rue Petite Vitesse, F-37300 Toulouse, France
[3] Ctr Oscar Lambret, Dept Radiotherapie, 3 Rue Freder Combemale, F-59000 Lille, France
[4] Univ Paris, Hop Cochin, AP HP, Serv Radiol A,Unite Radiol Abdominopelvienne & In, 27 Rue Faubourg St Jacques, F-75014 Paris, France
[5] Univ Paris, Hop Bichat, AP HP, Unite Inserm U1152,Serv Chirurg Vasc Thorac & Tra, 46 Rue Henri Huchard, F-75018 Paris, France
[6] Hop Cochin, Inst Necker Enfants Malad, Serv Urol, Inserm U1151 Equipe 4, 27 Rue Faubourg St Jacques, F-75014 Paris, France
[7] Univ Paris, Hop Europeen Georges Pompidou, AP HP, Serv Oncol Radiotherapie, 20 Rue Leblanc, F-75015 Paris, France
来源
CANCER RADIOTHERAPIE | 2020年 / 24卷 / 6-7期
关键词
Stereotactic radiotherapy; Minimally invasive surgery; Interventional radiology; Lung cancer; Prostate cancer; Hepatic cancer; BODY RADIATION-THERAPY; CELL LUNG-CANCER; QUALITY-OF-LIFE; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; RADICAL PROSTATECTOMY; FOLLOW-UP; PHASE-II; OUTCOMES; GUIDELINES;
D O I
10.1016/j.canrad.2020.06.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Stereotactic radiotherapy is a fundamental change from the conventional fractionated radiotherapy and represents a new therapeutic indication. Stereotactic radiotherapy is now a standard of care for inoperable patients or patients who refuse surgery. The results are encouraging with local control and survival rates very high in selected populations. The rate of late toxicity remains acceptable. Good tolerability makes it appropriate even for elderly and frail patients. In these fragile patients or in certain specific clinical situations, different surgical, radiotherapy or interventional radiology attitudes can be discussed on a case-by-case basis. These situations are considered in this article for the pulmonary, hepatic and prostatic localizations. (C) 2020 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:513 / 522
页数:10
相关论文
共 50 条
[31]   Feasibility of using intermediate x-ray energies for highly conformal extracranial radiotherapy [J].
Dong, Peng ;
Yu, Victoria ;
Dan Nguyen ;
Demarco, John ;
Woods, Kaley ;
Boucher, Salime ;
Low, Daniel A. ;
Sheng, Ke .
MEDICAL PHYSICS, 2014, 41 (04)
[32]   Stereotactic ablative radiotherapy delivered by image-guided helical tomotherapy for extracranial oligometastases [J].
Sole, C. V. ;
Lopez Guerra, J. L. ;
Matute, R. ;
Jaen, J. ;
Puebla, F. ;
Rivin, E. ;
Sanchez-Reyes, A. ;
Beltran, C. ;
Bourgier, C. ;
Calvo, F. A. ;
Marsiglia, H. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (06) :484-491
[33]   Adopting Advanced Radiotherapy Techniques in the Treatment of Paediatric Extracranial Malignancies: Challenges and Future Directions [J].
Lavan, N. A. ;
Saran, F. H. ;
Oelfke, U. ;
Mandeville, H. C. .
CLINICAL ONCOLOGY, 2019, 31 (01) :50-57
[34]   Stereotactic body radiotherapy for primary prostate cancer: A systematic review [J].
Tan, Tze-Jian ;
Siva, Shankar ;
Foroudi, Farshad ;
Gill, Suki .
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2014, 58 (05) :601-611
[35]   The Feasibility and Efficacy of Stereotactic Body Radiotherapy for Centrally-located Lung Tumors [J].
Takahashi, Wataru ;
Yamashita, Hideomi ;
Omori, Mami ;
Kitaguchi, Mayuka ;
Shibata-Kobayashi, Shino ;
Sakumi, Akira ;
Nakagawa, Keiichi .
ANTICANCER RESEARCH, 2013, 33 (11) :4959-4964
[36]   Prognostic factors and clinical outcomes after stereotactic radiotherapy for primary lung tumors [J].
Rodrigues, Isabel ;
Figueiredo, Tiago ;
Gagean, Joao ;
Ferreira, Carolina ;
Laranja, Andre ;
Ramos, Tiago ;
Conde, Sofia ;
Moreira, Diana ;
Cardia, Joana .
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2020, 25 (06) :943-950
[37]   A new prognostic model for brain metastases of specific primary tumors with stereotactic radiotherapy [J].
Gu, L. ;
Qing, S. ;
Zhang, H. -j. .
CANCER RADIOTHERAPIE, 2023, 27 (03) :183-188
[38]   Palliative Radiotherapy for Symptomatic Primary Tumors in Patients With Locally Advanced Breast Cancer [J].
Kim, Jae Sik ;
Chang, Jee Suk ;
Kim, Kyubo .
JOURNAL OF BREAST CANCER, 2024, 27 (04) :223-234
[39]   Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy [J].
Saelen, Marie G. ;
Hjelle, Line V. ;
Aarsaether, Erling ;
Knutsen, Tore ;
Andersen, Sigve ;
Bentzen, Anne G. ;
Richardsen, Elin ;
Fossa, Sophie D. ;
Haugnes, Hege S. .
ACTA ONCOLOGICA, 2023, 62 (06) :657-665
[40]   The risk/benefit ratio of radiotherapy in pituitary tumors [J].
Minniti, Giuseppe ;
Flickinger, John .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 33 (02)